Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Ciudad Autónoma de Buenos Aires; Argentina. Ministerio de Salud de la Nación; 2017. 124 p. (Temas de Salud Ambiental, 21).
Monografia em Espanhol | LILACS, ARGMSAL, BINACIS | ID: biblio-1014977

RESUMO

Esta publicación tiene como objetivo analizar la situación de la normativa relacionada con la gestión interna de los residuos biopatogénicos en los establecimientos de atención de la salud. Se realizó una revisión comparativa de las leyes provinciales y de sus decretos reglamentarios a fin de identificar los criterios empleados como base para proponer una adecuación de la normativa nacional con un criterio integrador. La descripción de situaciones particulares obedece a la necesidad de poner de manifiesto las diversidades y coincidencias o los hallazgos en algunas jurisdicciones que son interesantes de replicar en otras o que por el contrario ameritan una revisión local en el contexto del avance del conocimiento y de la disponibilidad de tecnologías. La omisión de una jurisdicción en una descripción no implica necesariamente la ausencia de ese tema su marco legislativo.


Assuntos
Saúde Ocupacional , Armazenamento de Substâncias e Resíduos Perigosos , Classificação de Resíduos Sólidos Urbanos , Resíduos de Serviços de Saúde
2.
Rev. argent. salud publica ; 6(24): 7-14, sept. 2015. tab
Artigo em Espanhol | LILACS | ID: biblio-869543

RESUMO

INTRODUCCIÓN: la gestión de los residuos de establecimientos de atención de la salud plantea variados problemas técnicos y es influida por las circunstancias culturales, sociales yeconómicas. En Argentina, la operación está inmersa en un complejo escenario legal donde coexisten 18 marcos legislativos diferentes para residuos biopatogénicos. OBJETIVOS: Proveer las herramientas para la construcción colectiva y federal de presupuestos mínimos en la materia. MÉTODOS: Se realizó una revisión comparativa de las leyes provinciales y sus decretos reglamentarios, cotejándolas con la ley nacional para cada aspecto y siguiendo las sucesivas etapas de la gestión interna de los residuos generados en establecimientos de atención de la salud. RESULTADOS: Se relevaron 67 normas: 5 nacionales, 40 leyes provinciales y 22 decretos provinciales. En la mayoría de los ítems comparados se observó una gran diversidad de criterios y diferente nivel de profundización. CONCLUSIONES: Argentina necesita poner en agenda la actualización de las normativas de residuos de establecimientos de atención de la salud con un enfoque inclusivo de la salud ambiental y laboral, para construir presupuestos mínimos en la temática de manera colectiva y federal.


INTRODUCTION: health care waste management poses various technical problems and is influenced by cultural,social and economic contexts. In Argentina, this takes place in a complex legal scenario with the coexistence of 18 different legalframeworks for bio-pathogenic waste. OBJECTIVES: To provide the tools for the collective federal construction of mínimum agreements in this field. METHODS: A comparative review wasperformed on provincial laws and their regulatory decrees. It involved a comparison with the national law for every aspect, following the successive stages of internal health care wastemanagement. RESULTS: The review included 67 legal dispositions: 5 at national level, 40 provincial laws and 22 provincial decrees. Most of the items showed a great diversity of criteria and different depth level. CONCLUSIONS: Argentina needs toupdate the regulations on health care waste management with an inclusive approach to environmental and occupational health, in order to develop the collective federal construction of minimum agreements.


Assuntos
Humanos , Resíduos Perigosos , Resíduos de Serviços de Saúde
3.
s.l; s.n; mar. 2010. [{"_e": "", "_c": "", "_b": "tab", "_a": ""}].
Não convencional em Espanhol | LILACS, BRISA/RedTESA | ID: biblio-833581

RESUMO

Objetivo: Evaluar la evidencia disponible de la efectividad de la técnica de sangre oculta en materia fecal para la detección precoz del cáncer colorrectal, en población general con riesgo medio. Metodología: Se utilizó un método dual de revisión sistemática en las principales bases de datos generales y especializadas (Google, Pubmed, LILACS, Tripdatabase, INAHTA, COCHRANE, NGC, AUnETS), priorizando la búsqueda de revisiones sistemáticas o metanálisis y evaluaciones de tecnología sanitaria. Resultados: Se identificaron 2 evaluaciones de tecnología sanitaria, 4 revisiones sistemáticas y 1 revisión Cochrane, entre los años 2007 y 2010. Conclusiones: La mortalidad por cáncer colorrectal en población de riesgo medio, se reduce por el screening con el test de sangre oculta en materia fecal y tiene probabilidad de evitar aproximadamente 1 de cada 6 muertes por cáncer colorrectal. Evidencia limitada o indirecta de que el TIF tenga Sensibilidad /especificidad superior al de TSOMFg sin rehidratar para detección de CCR.(AU)


Assuntos
Humanos , Neoplasias Colorretais/diagnóstico , Neoplasias Colorretais/prevenção & controle , Programas de Rastreamento/métodos , Sangue Oculto , Fatores de Risco , Análise Custo-Benefício
6.
Medicina [B.Aires] ; 57(Supl.2): 55-69, Ago. 1997.
Artigo em Espanhol | BINACIS | ID: bin-7445

RESUMO

We have developed an experimental model in which the administration of progestins induces mammary tumors in female virgin BALB/c mice. In this paper we review the morphological and biological features of progestin-induced tumors, such as estrogen receptor (ER) and progesterone receptor (PR) patterns of expression, hormone dependence and epidermal growth factor receptors (EGF-R) we also examine our data concerning the systemic effects of medroxyprogesterone acetate (MPA) as regards its stimulating EGF synthesis in salivary glands and its subsequent increase in serum. This growth factor seems to play an important role in the induction of mammary tumors. Direct MPA proliferative effects mediated by PR were demonstrated using primary cultures of progestin-dependent (PD) mammary tumors. Antiprogestins inhibited cell growth beyond control values, suggesting that PR are involved in cell proliferation even in the absence of the ligand. Progesterone-independent (PI) tumors expressing high levels of PR and ER are also inhibited by estrogen or antiprogestin treatment, suggesting that PR are involved in the control of autonomous tumor growth. Estrogen-resistant variants may be selected which may revert to an estrogen-sensitive phenotype after several transplants in untreated mice. The similarities between the tumors obtained with this model and human breast cancer as regards morphological features, evolution and the regulation of growth control converts this model into a useful tool to explore the mechanisms related with acquisition of hormone independence and autonomous tumor growth.(Au)


Assuntos
Humanos , Animais , Feminino , Criança , Camundongos , RESEARCH SUPPORT, NON-U.S. GOVT , Adenocarcinoma/patologia , Neoplasias Mamárias Experimentais/patologia , Neoplasias Hormônio-Dependentes/patologia , Receptores ErbB/análise , Receptores de Estrogênio/análise , Receptores de Progesterona/análise , Adenocarcinoma/induzido quimicamente , Progressão da Doença , Neoplasias Pulmonares/secundário , Neoplasias Mamárias Experimentais/induzido quimicamente , Acetato de Medroxiprogesterona , Camundongos Endogâmicos BALB C
7.
Medicina (B.Aires) ; 57(Supl.2): 55-69, Aug. 1997.
Artigo em Espanhol | LILACS | ID: lil-320009

RESUMO

We have developed an experimental model in which the administration of progestins induces mammary tumors in female virgin BALB/c mice. In this paper we review the morphological and biological features of progestin-induced tumors, such as estrogen receptor (ER) and progesterone receptor (PR) patterns of expression, hormone dependence and epidermal growth factor receptors (EGF-R) we also examine our data concerning the systemic effects of medroxyprogesterone acetate (MPA) as regards its stimulating EGF synthesis in salivary glands and its subsequent increase in serum. This growth factor seems to play an important role in the induction of mammary tumors. Direct MPA proliferative effects mediated by PR were demonstrated using primary cultures of progestin-dependent (PD) mammary tumors. Antiprogestins inhibited cell growth beyond control values, suggesting that PR are involved in cell proliferation even in the absence of the ligand. Progesterone-independent (PI) tumors expressing high levels of PR and ER are also inhibited by estrogen or antiprogestin treatment, suggesting that PR are involved in the control of autonomous tumor growth. Estrogen-resistant variants may be selected which may revert to an estrogen-sensitive phenotype after several transplants in untreated mice. The similarities between the tumors obtained with this model and human breast cancer as regards morphological features, evolution and the regulation of growth control converts this model into a useful tool to explore the mechanisms related with acquisition of hormone independence and autonomous tumor growth.


Assuntos
Humanos , Animais , Feminino , Criança , Camundongos , Adenocarcinoma , Neoplasias Hormônio-Dependentes/patologia , Neoplasias Mamárias Experimentais/patologia , Receptores ErbB/análise , Receptores de Estrogênio/análise , Receptores de Progesterona , Adenocarcinoma , Progressão da Doença , Neoplasias Pulmonares , Acetato de Medroxiprogesterona , Camundongos Endogâmicos BALB C , Neoplasias Mamárias Experimentais/induzido quimicamente
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...